Reprogramming of IL-10 activity and signaling by IFN-γ1

被引:113
作者
Herrero, C
Hu, XY
Li, WP
Samuels, S
Sharif, MN
Kotenko, S
Ivashkiv, LB
机构
[1] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA
[2] Cornell Univ, Weill Grad Sch Med Sci, Grad Program Immunol, New York, NY 10021 USA
[3] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA
[4] Hosp Special Surg, Dept Med, New York, NY 10021 USA
关键词
D O I
10.4049/jimmunol.171.10.5034
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
One important mechanism of cross-regulation by opposing cytokines is inhibition of signal transduction, including inhibition of Janus kinase-STAT signaling by suppressors of cytokine signaling. We investigated whether IFN-gamma, a major activator of macrophages, inhibited the activity of IL-10, an important deactivator. Preactivation of macrophages with IFN-gamma inhibited two key anti-inflammatory functions of IL-10, the suppression of cytokine production and of MHC class II expression. Gene expression profiling showed that IFN-gamma broadly suppressed the ability of IL-10 to induce or repress gene expression. Although IFN-gamma induced expression of suppressor of cytokine signaling proteins, IL-10 signal transduction was not suppressed and IL-10 activation of Janus kinases and Stat3 was preserved. Instead, IFN-gamma switched the balance of IL-10 STAT activation from Stat3 to Stat1, with concomitant activation of inflammatory gene expression. IL-10 activation of Stat1 required the simultaneous presence of IFN-gamma. These results demonstrate that IFN-gamma operates a switch that rapidly regulates STAT activation by IL-10 and alters macrophage responses to IL-10. Dynamic regulation of the activation of different STATs by the same cytokine provides a mechanism by which cells can integrate and balance signals delivered by opposing cytokines, and extends our understanding of cross-regulation by opposing cytokines to include reprogramming of signaling and alteration of function.
引用
收藏
页码:5034 / 5041
页数:8
相关论文
共 44 条
[1]  
Avdiushko R, 2001, J LEUKOCYTE BIOL, V70, P624
[2]   INTERLEUKIN-10 ADMINISTRATION DECREASES SURVIVAL IN MURINE RECIPIENTS OF MAJOR HISTOCOMPATIBILITY COMPLEX DISPARATE DONOR BONE-MARROW GRAFTS [J].
BLAZAR, BR ;
TAYLOR, PA ;
SMITH, S ;
VALLERA, DA .
BLOOD, 1995, 85 (03) :842-851
[3]   The role of STATs in transcriptional control and their impact on cellular function [J].
Bromberg, J ;
Darnell, JE .
ONCOGENE, 2000, 19 (21) :2468-2473
[4]   IL-10 stimulates production of platelet-activating factor by monocytes of patients with active systemic lupus erythematosus (SLE) [J].
Bussolati, B ;
Rollino, C ;
Mariano, F ;
Quarello, F ;
Camussi, G .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 122 (03) :471-476
[5]   Mutational switch of an IL-6 response to an interferon-γ-like response [J].
Costa-Pereira, AP ;
Tininini, S ;
Strobl, B ;
Alonzi, T ;
Schlaak, JF ;
Is'harc, H ;
Gesualdo, I ;
Newman, SJ ;
Kerr, IM ;
Poli, V .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (12) :8043-8047
[6]   Evidence for a dual mechanism for IL-10 suppression of TNF-α production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-κB in primary human macrophages [J].
Denys, A ;
Udalova, IA ;
Smith, C ;
Williams, LM ;
Ciesielski, CJ ;
Campbell, J ;
Andrews, C ;
Kwaitkowski, D ;
Foxwell, BMJ .
JOURNAL OF IMMUNOLOGY, 2002, 168 (10) :4837-4845
[7]   Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression [J].
Dickensheets, HL ;
Venkataraman, C ;
Schindler, U ;
Donnelly, RP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (19) :10800-10805
[8]   Suppressor. of cytokine signaling 1 inhibits IL-10-mediated immune responses [J].
Ding, YZ ;
Chen, DM ;
Tarcsafalvi, A ;
Su, RH ;
Qin, LH ;
Bromberg, JS .
JOURNAL OF IMMUNOLOGY, 2003, 170 (03) :1383-1391
[9]   Targeted disruption of the mouse STAT1 results in compromised innate immunity to viral disease [J].
Durbin, JE ;
Hackenmiller, R ;
Simon, MC ;
Levy, DE .
CELL, 1996, 84 (03) :443-450
[10]  
FINBLOOM DS, 1995, J IMMUNOL, V155, P1079